To protect patient confidentiality, Abiomed, manufacturers AbioCor artificial heart, take a 30-day "quiet period" surrounding the implant, which is interpreted by the media as "news blackout". In late 2002, James Quinn, fifth transplant recipient, died after 289 days. A month later, the New York Times article describing the pain and suffering of Quinn, Quinn's widow claims that her husband had not been properly informed of the possible tests. This case raises issues of transparency and communication with stakeholders. The case may lead some students to focus on the social history of sensationalism surrounding Quinn, but a closer examination of the case shows that the more pressing issue for Abiomed is suspended clinical trials on track and bouying share price decline. B-case provides a detailed epilogue, including reactions to Quinns "informed consent claim and appeal Abiomed about ongoing clinical trials and investor relations." Hide
by Elizabeth A. Powell, Rebecca A. Goldberg Source: Darden School of Business 18 pages. Publication Date: January 25, 2010. Prod. #: UV4246-PDF-ENG
Related Case Solutions & Analyses:
Tong Lung Metal Industry Co. Ltd.
Nantero
Centre Partners–American Seafoods 2006
Harvard Stem Cell Institute
Queueing Theory
Point of View Assignment
Eli Lilly–1998 (B): Emerging Global Organization
High Places Studio A
Bitter Competition: The Holland Sweetener Co. vs. NutraSweet (A), Portuguese Version
The Turnaround Man part A
